Effectiveness of Early Parent-Based Language Intervention
NCT ID: NCT00625261
Last Updated: 2008-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
150 participants
INTERVENTIONAL
2003-10-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the last few years various forms of early language intervention have been increasingly implemented in German speaking countries. However, they have not been evaluated.
Early parent-based intervention could be an economical way in prevention speech and language disorders.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
The mothers of the two-years old children in the intervention group took part at the Heidelberg Parent-based Language Intervention HPLI
Heidelberg Parent-based Language Intervention HPLI
The HPLI is a group program for parents of young children with language delay. This 12-14week program includes seven two-our sessions and one three-our session six months later. It is designed for 5 to 10 people and based of an interactive model of language intervention, wich presumes that optimized parental input will provide better language-learning opportunities.
2
Waiting group, no intervention until children were three years of age
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heidelberg Parent-based Language Intervention HPLI
The HPLI is a group program for parents of young children with language delay. This 12-14week program includes seven two-our sessions and one three-our session six months later. It is designed for 5 to 10 people and based of an interactive model of language intervention, wich presumes that optimized parental input will provide better language-learning opportunities.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Children with previous language intervention
24 Months
27 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Pediatric Neurology, Chidren“s Hospital, University of Heidelberg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anke Buschmann, MA
Role: PRINCIPAL_INVESTIGATOR
Department of Pediatric Neurology, Children“s Hospital, University of Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatric Neurology, Childrens Hospital, University of Heidelberg
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
243/2002
Identifier Type: -
Identifier Source: org_study_id